BackAntares Pharma Overview

Antares Pharma Other Liabilities

Track Antares Pharma's other liabilities ($1.2M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Liabilities
$1.21M
↑ 66.25% YoYΔ $481000.00 vs prior year quarter

Peer average

Loading

Antares Pharma Other Liabilities History

Loading

Antares Pharma vs. peers: Other Liabilities Comparison

Loading

Antares Pharma Other Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Antares Pharma (ATRS) FAQ

As of the most recent data (March 2022), ATRS shows a other liabilities of $1.2M. That compares with $730K in the prior-year period — up 66.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ATRS's other liabilities is now $1.2M (was $730K) — a 66.3% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Antares Pharma is outperforming or lagging.

Tracking ATRS's other liabilities over time shows whether Antares Pharma is scaling, shrinking, or reshaping that part of the business. The current reading is $1.2M That compares with $730K in the prior-year period — up 66.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other liabilities page, Stockcircle has Antares Pharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other liabilities (currently $1.2M) with ownership activity and broader fundamentals.

Antares Pharma's other liabilities is $1.2M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.